[IMRX] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[IMRX] Immuneering Corporation
Announcement Date
09-Sep-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -28.22%
YoY- -121.64%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 184 190 482 660 748 665 683 -58.32%
PBT -12,897 -11,092 -8,534 -7,987 -6,230 -5,836 -4,399 104.97%
Tax -29 -307 -17 1 0 42 -0 -
NP -12,867 -10,784 -8,534 -7,988 -6,230 -5,836 -4,399 104.65%
Tax Rate - - - - - - - -
Total Cost 13,051 10,974 9,016 8,648 6,978 6,501 5,082 87.63%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin -7,004.48 -5,688.22 -1,770.08 -1,210.18 -832.62 -877.48 -644.49 391.36%
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -0.49 -0.42 -0.47 -0.33 -0.46 -0.43 -0.33 30.18%
EPS Diluted -0.49 -0.42 -0.47 -0.33 -0.46 -0.43 -0.33 30.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.